(Q36994582)

17 August 2017

title

Gangliosides as targets for autoimmune injury to the nervous system (English)

1 reference

17 August 2017

Hugh J Willison

1

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

Journal of Neurochemistry

17 August 2017

published in

1 reference

17 August 2017

volume

103 Suppl 1

1 reference

17 August 2017

page(s)

143-149

1 reference

Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

An acute axonal form of Guillain-Barré polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

The relationship of neuromuscular synapse elimination to synaptic degeneration and pathology: insights from WldS and other mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Immune mechanisms in inflammatory polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

21 January 2018

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Serum antibodies to gangliosides in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Ganglioside complexes as new target antigens in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Anti-ganglioside complex antibodies in Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Combinatorial ganglioside biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Experimental sensory neuropathy induced by sensitization with ganglioside GD1b

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

The refractory period of transmission is impaired in axonal Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Ganglioside structures and distribution: Are they localized at the nerve ending?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Gangliosides: structure, isolation, and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Glycobiology of the neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

The possibilities and pitfalls for anti-complement therapies in inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Interaction of botulinum and tetanus toxins with the lipid bilayer surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Anti-GQ1b IgG antibody syndrome: clinical and immunological range

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Gangliosides and glycosphingolipids of peripheral nervous system myelins--a minireview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Multifocal motor neuropathy human sera block distal motor nerve conduction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

The immunopathogenesis of Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Peripheral neuropathies and anti-glycolipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Bacterial infections in Guillain-Barré and Fisher syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Patterns of recovery in the Guillain-Barre syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Physiologic-pathologic correlation in Guillain-Barre syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04718.X

An Unusual Variant of Acute Idiopathic Polyneuritis (Syndrome of Ophthalmoplegia, Ataxia and Areflexia)

21 January 2018

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

Anti-PMP22 antibodies in patients with inflammatory neuropathy

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

Anti-ganglioside complex antibodies associated with severe disability in GBS

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

Leukocyte and complement activation by GM1-specific antibodies is associated with acute motor axonal neuropathy in rabbits

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

Ganglioside complexes: new autoantibody targets in Guillain-Barré syndromes

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

Campylobacter Enteritis and the Guillain-Barré Syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

b-series Ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

The role of GM1 and other gangliosides in neuronal differentiation. Overview and new finding

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1471-4159.2007.04718.X

Identifiers

DOI

10.1111/J.1471-4159.2007.04718.X

1 reference

17 August 2017

1 reference